Health Care & Life Sciences » Biotechnology | Onconova Therapeutics Inc.

Onconova Therapeutics Inc.

Onconova Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
-
Public Float
1.61 M
Onconova Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$4.33
Market Cap
$17.04 M
Shares Outstanding
6 M
Public Float
5.4 M

Profile

Address
375 Pheasant Run
Newtown Pennsylvania 18940
United States
Employees -
Website http://www.onconova.com
Updated 07/08/2019
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E.

Financials

View All
Created with Highcharts 5.0.14Onconova Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.64 86364 86363 68263 68223 97923 97919 66719 66724 09224 09220 57320 573201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14Onconova Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.4 7534 75380080011 45611 4565 5465 5467877871 2281 22820132014201520162017201802.5k5k7.5k10k12.5k

Ramesh Kumar
Chief Executive Officer & Director
E. Premkumar Reddy
Director